FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912113425> ?p ?o ?g. }

• W2912113425 endingPage "1422" @default.
• W2912113425 startingPage "1414" @default.
• W2912113425 abstract "Novel immune checkpoint blockades, including those targeting CD73 and A2aR, are being evaluated in malignancies in clinical trials. Here, we investigated the expression of CD73 and A2aR as well as tumor-infiltrating lymphocytes (TILs), and analyzed their correlations with clinicopathological characteristics and survival in diffuse large B-cell lymphoma (DLBCL). We found that CD73 expression on tumor cells, rather than the total protein and gene levels of CD73, was associated with survival. Patients with CD73+ /Pax-5+ (median survival, 57.8 months; 95% CI, 46.4-69.3) experienced significantly poorer outcomes than those with CD73- /Pax-5+ (median survival, 73.5 months; 95% CI, 65.9-81.2). Additionally, A2aR expression on both total TILs and CD8+ TILs was correlated with survival. Patients with A2aR+ TILs (median survival, 53.3 months; 95% CI, 40.6-66.0) had a significantly shorter survival time than patients with A2aR- TILs (median survival, 74.5 months; 95% CI, 67.5-81.5). Spearman's rank test showed that CD73 expression on tumor cells was positively correlated with A2aR expression on TILs (R = 0.395, p = 0.001). We further found that patients could be more precisely stratified through the combination of CD73 tumor cell expression and A2aR TILs expression, and patients with CD73+ /Pax-5+ and A2aR+ TILs experienced the worst outcome. We also revealed that patients with CD73+ /Pax-5+ and low CD8+ TILs or low absolute lymphocyte counts had unfavorable outcomes. Overall, our findings uncovered that patients with CD73+ on tumor cells as well as A2aR+ on TILs or low CD8+ TILs exhibited inferior survival, supporting potential combination strategies using CD73/A2aR immunosuppressive blockades as treatment options for DLBCL patients." @default.
• W2912113425 created "2019-02-21" @default.
• W2912113425 creator A5001135284 @default.
• W2912113425 creator A5001659843 @default.
• W2912113425 creator A5003226007 @default.
• W2912113425 creator A5006621752 @default.
• W2912113425 creator A5013736647 @default.
• W2912113425 creator A5027059038 @default.
• W2912113425 creator A5035282947 @default.
• W2912113425 creator A5035331753 @default.
• W2912113425 creator A5039962884 @default.
• W2912113425 creator A5041665648 @default.
• W2912113425 creator A5042008157 @default.
• W2912113425 creator A5044172930 @default.
• W2912113425 creator A5047452249 @default.
• W2912113425 creator A5066273890 @default.
• W2912113425 creator A5067681000 @default.
• W2912113425 creator A5074653520 @default.
• W2912113425 creator A5078752570 @default.
• W2912113425 creator A5082176762 @default.
• W2912113425 date "2019-02-04" @default.
• W2912113425 modified "2023-10-13" @default.
• W2912113425 title "Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome" @default.
• W2912113425 cites W1759669640 @default.
• W2912113425 cites W1889335134 @default.
• W2912113425 cites W1977187462 @default.
• W2912113425 cites W2018071905 @default.
• W2912113425 cites W2019142781 @default.
• W2912113425 cites W2030897133 @default.
• W2912113425 cites W2039123767 @default.
• W2912113425 cites W2049601932 @default.
• W2912113425 cites W2053908301 @default.
• W2912113425 cites W2054661897 @default.
• W2912113425 cites W2077703512 @default.
• W2912113425 cites W2097378932 @default.
• W2912113425 cites W2102478114 @default.
• W2912113425 cites W2144174481 @default.
• W2912113425 cites W2160141570 @default.
• W2912113425 cites W2166292888 @default.
• W2912113425 cites W2166460475 @default.
• W2912113425 cites W2166798770 @default.
• W2912113425 cites W2321985702 @default.
• W2912113425 cites W2412725897 @default.
• W2912113425 cites W2519184848 @default.
• W2912113425 cites W2562160912 @default.
• W2912113425 cites W2746942980 @default.
• W2912113425 cites W2753945613 @default.
• W2912113425 cites W2769890142 @default.
• W2912113425 cites W2791483720 @default.
• W2912113425 cites W4250417345 @default.
• W2912113425 doi "https://doi.org/10.1002/ijc.32144" @default.
• W2912113425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30664812" @default.
• W2912113425 hasPublicationYear "2019" @default.
• W2912113425 type Work @default.
• W2912113425 sameAs 2912113425 @default.
• W2912113425 citedByCount "22" @default.
• W2912113425 countsByYear W29121134252019 @default.
• W2912113425 countsByYear W29121134252020 @default.
• W2912113425 countsByYear W29121134252021 @default.
• W2912113425 countsByYear W29121134252022 @default.
• W2912113425 countsByYear W29121134252023 @default.
• W2912113425 crossrefType "journal-article" @default.
• W2912113425 hasAuthorship W2912113425A5001135284 @default.
• W2912113425 hasAuthorship W2912113425A5001659843 @default.
• W2912113425 hasAuthorship W2912113425A5003226007 @default.
• W2912113425 hasAuthorship W2912113425A5006621752 @default.
• W2912113425 hasAuthorship W2912113425A5013736647 @default.
• W2912113425 hasAuthorship W2912113425A5027059038 @default.
• W2912113425 hasAuthorship W2912113425A5035282947 @default.
• W2912113425 hasAuthorship W2912113425A5035331753 @default.
• W2912113425 hasAuthorship W2912113425A5039962884 @default.
• W2912113425 hasAuthorship W2912113425A5041665648 @default.
• W2912113425 hasAuthorship W2912113425A5042008157 @default.
• W2912113425 hasAuthorship W2912113425A5044172930 @default.
• W2912113425 hasAuthorship W2912113425A5047452249 @default.
• W2912113425 hasAuthorship W2912113425A5066273890 @default.
• W2912113425 hasAuthorship W2912113425A5067681000 @default.
• W2912113425 hasAuthorship W2912113425A5074653520 @default.
• W2912113425 hasAuthorship W2912113425A5078752570 @default.
• W2912113425 hasAuthorship W2912113425A5082176762 @default.
• W2912113425 hasBestOaLocation W29121134251 @default.
• W2912113425 hasConcept C126322002 @default.
• W2912113425 hasConcept C143998085 @default.
• W2912113425 hasConcept C167672396 @default.
• W2912113425 hasConcept C203014093 @default.
• W2912113425 hasConcept C2778326572 @default.
• W2912113425 hasConcept C2778559949 @default.
• W2912113425 hasConcept C2779338263 @default.
• W2912113425 hasConcept C71924100 @default.
• W2912113425 hasConcept C8891405 @default.
• W2912113425 hasConcept C90924648 @default.
• W2912113425 hasConceptScore W2912113425C126322002 @default.
• W2912113425 hasConceptScore W2912113425C143998085 @default.
• W2912113425 hasConceptScore W2912113425C167672396 @default.
• W2912113425 hasConceptScore W2912113425C203014093 @default.
• W2912113425 hasConceptScore W2912113425C2778326572 @default.
• W2912113425 hasConceptScore W2912113425C2778559949 @default.
• W2912113425 hasConceptScore W2912113425C2779338263 @default.

• next